glp 1 agonists and inflammation GLP-1 Drugs: For Multiple Chronic Conditions Anti-inflammatory properties of GLP-1 receptor
Description
Clinical Trial Results SURMOUNT-1 trial: Average weight loss of ~20% of total body weight
doi: 10.1159/000109998 [DOI] [PMC free article] [PubMed] [Google Scholar] 115
Front Med (Lausanne)
Injectable GLP-1 medication can help manage type 2 diabetes and, when combined with diet and exercise, aid weight loss
When estimating HRs for MOF in the full unmatched cohort, the unadjusted analysis yielded a highly significant difference between the groups
